A Randomized Study to Compare a Hydrogel Packing System to Standard Packing During HDR Brachytherapy for Cervical Cancer

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

21 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-17

Study Completion Date

2024-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, a new, low cost packing system ("BrachyGel VHPS") is being tested as a packing option during brachytherapy along with standard options to make sure that it keeps the unrelated organs away from radiation at least as well as the standard options, and to better understand the safety and patient discomfort associated with BrachyGel VHPS and the standard packing options.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies

NCT07292818

Cervix Cancer

NOT_YET_RECRUITING PHASE1

Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition

NCT00571415

Cervix Cancer

TERMINATED

The Long-term Benefit of Hydrogel Spacer in Reducing Rectal Radiation Dose in Cervical Cancer Radiation Therapy.

NCT05902390

Uterine Cervical Neoplasms

UNKNOWN NA

MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer

NCT03634267

Human Papillomavirus-Related Carcinoma Human Papillomavirus-Related Cervical Carcinoma Stage IB2 Cervical Cancer AJCC v8 +14 more

ACTIVE_NOT_RECRUITING PHASE1

An International Study on Magnetic Resonance Imaging (MRI)-Guided Brachytherapy in Locally Advanced Cervical Cancer

NCT00920920

Cervical Cancer

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

As part of vaginal brachytherapy, the organs that do not need to receive radiation (unrelated organs) are moved out of the way of the radiation with a "packing system". The usual low cost and available standard of care packing systems to move these unrelated organs out of the way can sometimes be uncomfortable for the patient, may not move all of the unrelated organs all the way out of the radiation's path, and rely on the doctor to place them correctly.

If you participate, you will receive 5 fractions of brachytherapy according to standard clinical care. For three of the fractions, a standard packing option will be used and for two of them BrachyGel VHPS will be used. For the first fraction both groups will have the same packing option but participants will be randomized to either have BrachyGel during fractions 2 and 4 or during fractions 3 and 5. You'll be asked to complete a questionnaire after fractions 2-5 to get your feedback on any discomfort you have during or after brachytherapy from the packing system.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cervical Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Both groups will have two fractions of brachytherapy with a standard packing system and two fractions of brachytherapy with BrachyGel VHPS - only the timing will be different between the two groups.

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm A: BrachyGel in fractions 3 and 5

BrachyGel VHPS in fractions 3 and 5 and standard packing in fractions 2 and 4

Group Type EXPERIMENTAL

BrachyGel VHPS

Intervention Type DEVICE

Packing system for administering brachytherapy in cervical cancer patients

Arm B: BrachyGel in fractions 2 and 4

BrachyGel VHPS in fractions 2 and 4 and standard packing in fractions 3 and 5

Group Type EXPERIMENTAL

BrachyGel VHPS

Intervention Type DEVICE

Packing system for administering brachytherapy in cervical cancer patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

BrachyGel VHPS

Packing system for administering brachytherapy in cervical cancer patients

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Biopsy showing cancer of the cervix (squamous cell carcinoma, adenocarcinoma, adenosquamous, neuroendocrine, etc)
2. FIGO IB1 - IVB Staging according to FIGO and TNM guidelines
3. Planning to receive brachytherapy as a part of the definitive treatment for cervical cancer
4. Karnofsky performance status (KPS) ≥ 70 or ECOG status ≤1
5. Stated willingness to comply with all study procedures and availability for the duration of the study
6. Age ≥ 18 years
7. Agreement to adhere to Lifestyle Considerations throughout study duration

Exclusion Criteria

1. History of pelvis or abdominal radiation therapy (RT) that is not a part of the definitive treatment plan for the cancer of interest"
2. History of total or partial hysterectomy
3. Plan to receive external beam RT (EBRT) alone as the definitive treatment plan for the cancer of interest
4. Known pregnancy or lactation (no pregnancy test required prior to participation)
5. Known contraindications to brachytherapy

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No